Humbert M - Search Results

1

[Liver diseases and pulmonary vascular disorders].

Riou M, Jutant EM, Mignard X, Canuet M, Humbert M, Sitbon O, Savale L, Montani D. Riou M, et al. Among authors: humbert m. Rev Med Interne. 2018 Dec;39(12):925-934. doi: 10.1016/j.revmed.2018.07.015. Epub 2018 Aug 30. Rev Med Interne. 2018. PMID: 30174113 Review. French.

2

Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Humbert M, et al. Am J Respir Crit Care Med. 1995 May;151(5):1628-31. doi: 10.1164/ajrccm.151.5.7735624. Am J Respir Crit Care Med. 1995. PMID: 7735624

3

Pulmonary vascular disorders in portal hypertension.

Hervé P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, Duroux P. Hervé P, et al. Among authors: humbert m. Eur Respir J. 1998 May;11(5):1153-66. doi: 10.1183/09031936.98.11051153. Eur Respir J. 1998. PMID: 9648972 Free article. Review.

4

Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin).

Humbert M, Sanchez O, Fartoukh M, Jagot JL, Sitbon O, Simonneau G. Humbert M, et al. Chest. 1998 Jul;114(1 Suppl):80S-82S. doi: 10.1378/chest.114.1_supplement.80s. Chest. 1998. PMID: 9676646 No abstract available.

5

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

Sitbon O, Humbert M, Jagot JL, Taravella O, Fartoukh M, Parent F, Herve P, Simonneau G. Sitbon O, et al. Among authors: humbert m. Eur Respir J. 1998 Aug;12(2):265-70. doi: 10.1183/09031936.98.12020265. Eur Respir J. 1998. PMID: 9727772 Free article.

6

Primary pulmonary hypertension associated with the use of fenfluramine derivatives.

Simonneau G, Fartoukh M, Sitbon O, Humbert M, Jagot JL, Hervé P. Simonneau G, et al. Among authors: humbert m. Chest. 1998 Sep;114(3 Suppl):195S-199S. doi: 10.1378/chest.114.3_supplement.195s. Chest. 1998. PMID: 9741568 Review.

7

Treatment of pulmonary hypertension secondary to connective tissue diseases.

Sanchez O, Humbert M, Sitbon O, Simonneau G. Sanchez O, et al. Among authors: humbert m. Thorax. 1999 Mar;54(3):273-7. doi: 10.1136/thx.54.3.273. Thorax. 1999. PMID: 10325906 Free PMC article. Review. No abstract available.

8

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

Humbert M, Sanchez O, Fartoukh M, Jagot JL, Le Gall C, Sitbon O, Parent F, Simonneau G. Humbert M, et al. Eur Respir J. 1999 Jun;13(6):1351-6. doi: 10.1183/09031936.99.13613579. Eur Respir J. 1999. PMID: 10445611 Free article. Clinical Trial.

9

Severe pulmonary hypertension in histiocytosis X.

Fartoukh M, Humbert M, Capron F, Maître S, Parent F, Le Gall C, Sitbon O, Hervé P, Duroux P, Simonneau G. Fartoukh M, et al. Among authors: humbert m. Am J Respir Crit Care Med. 2000 Jan;161(1):216-23. doi: 10.1164/ajrccm.161.1.9807024. Am J Respir Crit Care Med. 2000. PMID: 10619823

10

Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy.

Eddahibi S, Humbert M, Sediame S, Chouaid C, Partovian C, Maître B, Teiger E, Rideau D, Simonneau G, Sitbon O, Adnot S. Eddahibi S, et al. Among authors: humbert m. Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1493-9. doi: 10.1164/ajrccm.162.4.2003124. Am J Respir Crit Care Med. 2000. PMID: 11029367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,400 results

Search Page

Filters